CCI
LRMR icon

Columbus Circle Investors’s Larimar Therapeutics LRMR Stock Holding History

Columbus Circle Investors’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,001
Closed -$1.15M – 294
2015
Q3 		$1.15M Sell
3,001
-3,141
-51% -$1.42M 0.01% 243
2015
Q2 		$2.55M Buy
6,142
+2,965
+93% +$1.24M 0.02% 238
2015
Q1 		$1.51M Buy
+3,177
New +$1.51M 0.01% 254

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Columbus Circle Investors's LRMR Position: Q4 2015 in Review

Columbus Circle Investors sold out of Larimar Therapeutics (LRMR) in Q4 2015, closing a stake of 3,001 shares — an estimated $1.15M sold.

Columbus Circle Investors first reported a position in LRMR in Q1 2015 and held it in 3 quarters. The position peaked at $2.55M in Q2 2015. 87 funds tracked by Wall St. Rank hold LRMR as of Q4 2015.

  • Columbus Circle Investors reported no remaining Larimar Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Columbus Circle Investors sold 3,001 Larimar Therapeutics shares in Q4 2015, an estimated $1.15M.
  • Columbus Circle Investors first reported a position in Larimar Therapeutics in Q1 2015 and held it in 3 quarters.
  • Columbus Circle Investors's Larimar Therapeutics position peaked at $2.55M in Q2 2015.
  • 87 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q4 2015.

Based on Columbus Circle Investors's 13F filing for Q4 2015, filed 5 Feb 2016.